BEZ235 Trial in Patients With Advanced Endometrial Carcinoma

Summary

This is an open label and single arm study to investigate the safety and efficacy of BEZ235 in adult women with endometrial carcinoma whose disease progressed (or recurred) while on or after first-line antineoplastic treatment for advanced endometrial carcinoma.

Timeline

Start

2012-03

Primary completion

2014-09

Completion

2017-12

Drugs

Indications